The purpose of this cross-sectional study was to determine the attitudes of internal medicine physicians toward treating diabetes in different patient ethnic groups and compared with treating common chronic medical conditions in primary care.
METHODS
The survey instrument was administered to 55 internal medicine physicians. An e-mail message was sent to each physician with a hyperlink to a site where the survey could be completed. The instrument was a modified, quantitative 10-point scale designed to measure attitudes regarding the difficulty of treating diabetes.
RESULTS
Diabetes was perceived to be more difficult to treat than hyperlipidemia and angina. African Americans with diabetes were perceived to be more difficult to treat than Caucasian patients. Difficulty in treating diabetes was comparable to that for hypertension, arthritis, and congestive heart failure. Physicians were confident about treatment efficacy for diabetes and changing diabetes outcomes, but not about the adequacy of time and resources for diabetes treatment.
CONCLUSIONS
Diabetes was perceived as a difficult disease to treat, African American patients were more difficult to treat, and time and resources were inadequate for diabetes treatment. To improve diabetes care, there is a need to address these attitudes and concerns of internal medicine physicians.
Get full access to this article
View all access options for this article.
References
1.
1. National Institute of Diabetes and Digestive and Kidney Disorders. Diabetes Statistics. Bethesda, Md: National Institutes of Health; 1999. NIH publication 99-3892. Available at: www.niddk.nih.gov/health/diabetes/pubs/dmstats/dmstats.htm.
2.
2. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N Engl J Med. 1993;329: 977-986.
3.
3. United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
4.
4. United Kingdom Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with mefformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-865.
5.
5. United Kingdom Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317: 703-713.
6.
6. United Kingdom Prospective Diabetes Study (UKPDS) Group. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ. 1998;317: 720-726.
7.
7. American Diabetes Association. Clinical practice recommendations 2000. Diabetes Care. 2000;23(suppl 1): S1-S116.
8.
8. Harris MI. Medical care for patients with diabetes. Epidemiologic aspects. Ann Intern Med. 1996;124:117-122.
9.
9. Laine C, Caro JF. Preventing complications in diabetes mellitus: the role of the primary care physician. Med Clin North Am. 1996;80:457-474.
10.
10. Peters AL, Legorreta AP, Ossorio RC, Davidson MB. Quality of outpatient care provided to diabetic patients. A health maintenance organization experience. Diabetes Care. 1996;19:601-606.
11.
11. Streja DA, Rabkin SW. Factors associated with implementation of preventive care measures in patients with diabetes mellitus. Arch Intern Med. 1999;159:294-302.
12.
12. Glasgow RE, Boles SM, Calder D, Dreyer L, Bagdade J. Diabetes care practices in primary care: results from two samples and three measurement sets. Diabetes Educ. 1999;25:755-763.
13.
13. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999; 282:1458-1465.
14.
14. Anderson RM, Fitzgerald JT, Funnell MM, Gruppen LD. The third version of the diabetes attitude scale. Diabetes Care. 1998;21:1403-1407.
15.
15. Anderson RM, Donnelly MB, Davis WK. Controversial beliefs about diabetes and its care. Diabetes Care. 1992;15: 859-863.
16.
16. Anderson RM, Donnelly MB, Dedrick RF, Gressard CP. The attitudes of nurses, dietitians, and physicians toward diabetes. Diabetes Educ. 1991; 17:261-268.
17.
17. Kenny SJ, Smith PJ, Goldschmid MG, Newman JM, Herman WH. Survey of physician practice behaviors related to diabetes mellitus in the US. Physician adherence to consensus recommendations. Diabetes Care. 1993;16: 1507-1510.
18.
18. National Institutes of Health. Metabolic Control Matters: Nationwide Translation of the Diabetes Control and Complications Trial: Analysis and Recommendations. Bethesda, Md: National Institutes of Health; 1994. NIH publication 94-3773.
19.
19. Anderson RM, Herman WH, Davis JM, Freedman RP, Funnell MM, Neighbors HW. Barriers to improving diabetes care for blacks [editorial]. Diabetes Care. 1991;14:605-609.
20.
20. Larme AC, Pugh JA. Attitudes of primary care providers toward diabetes: barriers to guideline implementation. Diabetes Care. 1998;21: 1391-1396.
21.
21, Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S. Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med. 1999;14: 537-546.
22.
22. Freedman TG. "Why don't they come to Pike Street and ask us?" Black American women's health concerns. Soc Sci Med. 1998;47:941-947.
23.
23. Schoenberg NE, Amey CH, Coward RT. Diabetes knowledge and sources of information among African American and white older women. Diabetes Educ. 1998;24: 319-324.
24.
24. Nurss JR, El-Kebbi IM, Gallina DL, et al. Diabetes in urban African Americans: functional health literacy of municipal hospital outpatients with diabetes. Diabetes Educ. 1997;23:563-568.
25.
25. Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med. 2000; 160:2281-2286.
26.
26. Mehta SS, Wilcox CS, Schulman KA. Treatment of hypertension in patients with comorbidities: results from the Study of Hypertensive Prescribing Practices (SHyPP). Am J Hypertens. 1999;12:333-340.
27.
27. Smith NL, Psaty BM, Pitt B, Garg R, Gottdiener JS, Heckbert SR. Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995. Arch Intern Med. 1998;158:1074-1080.
28.
28. Stafford RS, Saglam D, Blumenthal D. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure. Arch Intern Med. 1997;157:2460-2464.
29.
29. Chin MH, Friedmann PD, Cassel CK, Lang RM. Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure. J Gen Intern Med. 1997;2:523-530.
30.
30. Chin MH, Goldman L. Factors contributing to the hospitalization of patients with congestive heart failure. Am J Public Health. 1997;87: 643-648.
